Search Results

Achilles Therapeutics, a company built on the research at UCL cancer institute, UCLH and the Francis Crick Institute has announced the closing of its Initial Public Offering in the United States.

Achilles Therapeutics, a company built on the research of Crick group leader Charlie Swanton and Sergio Quezada at the UCL Cancer Institute has raised £100 million in new investment.

DNA 'echoes' of viruses that infected our ancestors millions of years ago could help the immune system to identify and kill cancer cells

A new method to accurately record brain activity at scale has been developed by researchers at the Crick, Stanford University and UCL. The technique could lead to new medical devices to help amputees, people with paralysis or people with neurological conditions such as motor neurone disease.

GSK's Jo Redmond tells us about the move from industry to academia and how her experience at the Crick will shape her work back at GSK.

Charles Swanton explains how detecting circulating tumour DNA in the blood evolved from an idea into a potentially life-saving clinical test.